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German Investigations on Morbidity and
Mortality of Workers Exposed to
Vinyl Chloride
by H. Weber,* W. ReinI,* and E. Greisert
Two studies on mortality and morbidity of workers exposed to vinyl chloride monomer (VCM)
which have been carried out on behalf of the Ministry of Labour, Health and Social Affairs on
Northrhine-Westphalia are reported.
Vinyl Chloride Mortality Study
The aims of this study were to determine stan-
dardized mortality ratios (SMR) for male workers
exposed to VCM, using the mortality rates of the
West German male population as reference, to
study the SMRs of a cohort of workers of the
cnemical industry comparable concerning age dis-
tribution and observation period but not exposed to
VCM and to determine the SMR of a cohort of
workers in PVC-processing plants.
The study was designed as a historic cohort
study, covering the period from the beginning of
the VCM- and PVC-production in all ofthe German
plants till the end of 1974.
Table 1 shows the main characteristics of the
three cohorts investigated. Only Germans and
Austrians were included in data analysis because of
insufficient mortality data on various foreign na-
tionals employed in German factories. To deter-
mine the mortality rates of Austrians, West Ger-
man rates were used. To calculate expectations of
total mortality, the mortality rates ofthe adequate
years have been used. To calculate expectations of
specific causes of death for all years before 1968,
the rates of 1968 have been used; for the following
years the rates ofthe corresponding years. Follow-
ing the procedure applied by Tabershaw (1),
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weighting of observed cases of specific causes of
death according to unknown causes of death has
been done with weighting factors calculated sepa-
rately for three observation periods (up to 1959,
1960-1969, 1970-1974) as well as for six age groups.
In all of the cohorts, follow-up rates have been
near or above 90%. The percentage of causes of
death that could not be investigated due to loss or
deletion of death certificates varied from 7.3% to
13.1%. To calculate age-standardized mortality ratios
ofspecific causes ofdeath, weighting has been done
according to the procedure used by Tabershaw and
Gaffey(1)tocompensateforunknownorunidentified
causes of death.
Table 2 displays totalmortality as well as some of
the relevant specific causes of death. It can be
observed that the otherwise observed "healthy
worker effect" cannot be demonstrated in the
German cohorts exposed to VCM or employed in
PVC-processing plants.
In the VCM cohort there are significant eleva-
tions of SMR ofmalignancies of the lymphatic and
hematopoietic tissues (ICM 200-209), and ofmalig-
nancies ofthe GI tract (ICD 150-159). The latter is
due tothe paramount elevation ofSMR oftumors of
the liver (ICD 155).
It must be noted that there is a modest elevation
ofSMR oftumors ofthe liver also in the cohort not
exposed to VCM nor employed in PVC-processing
plants. No obvious explanation for this observation
can be offered. In addition elevated SMRs for
ischemic heart disease (ICD 410-414) can be found
in all of the three cohorts. Due to methodological
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vascular risk factors has been made. Therefore
these results are of minor interest.
When subdividing the VCM-exposed cohort ac-
cording to time of exposure there is a clear-cut
increase of the SMR of liver tumors with time
(Table 3). This seems to be highly suggestive of a
time-response pattern. As it has been impossible to
determine concentrations of VCM retrospectively
due to technological and methodological problems,
no dose-response pattern can be established. How-
ever time of exposure seems to be the best avail-
able guess for dose.
Subclassification according to observation period
Table 1. Characteristics of study cohorts.
Group I, VCM/PVC Group II, reference Group III, PVC
production group processing
Population (Germans + Austrians) 7.021 4.910 4.007
Man years 73.734 76.029 52.896
Follow-up completed till 12/31/74, % deceased 93.2 89.8 92.1
Observed 414 417 360
Expected 435 533 380
Unknown causes of death
No. 30 47 47
% 7.3 11.3 13.1
Total mortality (SMR) 95 78 95
Foreigners (excluding Austrians) 882 711 1.454
Deceased 6 6 10
Table 2. Standardized mortality ratios.
VCM/PVC Reference PVC
production group processing
ICD 8 Cause of death Obs. SMR Obs. SMR Obs. SMR
Total mortality 414 95 417 78 360 95
140-209 All malignant tumors 94 112 83 83 62 85
140-199 Malignant tumors of organs 79 103 77 83 60 89
200-209 Malignancies of lymphatic and hematopoetic tissues 15 214b 6 77 2 34
150-159 Malignant tumors of GI tract and peritoneum 45 149a 27 71 15 56
155 Malignant tumors of the liver 12 1523b 4 401a 3 434
191 Malignant tumors of the brain 2 162 2 184 5 535a
410-414 Ischemic heart disease 91 127a 115 131a 96 158b
410 Acute myocardial 66 114 83 120 69 143b
800-949 Accidents 61 137a 44 99 32 110
aBeyond 95% confidence interval (2).
bBeyond 99% confidence interval (2).
Table 3. Standardized mortality ratios by duration of exposure.
Duration of exposure, months
< 12 13-16 61-120 > 121
ICD 8 Cause of death Obs. SMR Obs. SMR Obs. SMR Obs. SMR
Total
mortality 53 93 138 102 93 87 130 96
140-199 Malignant tumors of organs 6 74 20 88 22 116 31 115
200-209 Malignancies of lymphatic and hematopoetic tissues 1 92 4 186 5 287 5 249
150-159 Malignant tumors of GI tract and peritoneum 3 101 12 135 13 173 17 158
155 Malignant tumors ofthe liver 0 - 2 874a 3 1525b 7 2528
191 Malignant tumors of the brain 0 - 0 - 1 350 1 278
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Observation period
To 1959 1960-69 1970-74 Total
ICD 8 Cause of death Obs. SMR Obs. SMR Obs. SMR Obs. SMR
140-199 Malignant tumors 12 160 29 84 194 103 414 95
200-209 Malignancies of lymphatic and
hematopoetic tissues 1 147 9 275b 5 168 15 214b
150-159 Malignant tumors of GI tract and peritoneum 8 270a 13 94 24 177b 45 149a
155 Malignant tumors of the liver 1 1282 3 834a 8 2264b 12 1523b
191 Malignant tumors of the brain 1 557 0 - 1 223 2 162
aBeyond 95% confidence interval.
bBeyond 99% confidence interval.
Table 5. Standardized mortality ratios by age.
Age group
S 24 25-34 35-44 45-54 55-64 2 65 Total
ICD 8 Cause of death Obs. SMR Obs. SMR Obs. SMR Obs. SMR Obs. SMR Obs. SMR Obs. SMR
Total
mortality 10 68 45 111 65 104 90 101 105 80 90 103 414 95
140-199 Malignant tumors of organs 0 - 4 141 13 188a 19 141 22 76 21 100 79 103
200-209 Malignancies of lymphatic
and hematopoetic tissues 0 - 2 194 4 303 4 264 3 162 2 197 15 214
150-159 Malignant tumors of GI
tract and peritoneum 0 - 3 397 10 365b 10 145 10 89 12 140 45 149b
155 Malignant tumors of
theliver 0 - 0 - 6 6865b 0 3 3 934b 3 1664b 12 1523b
191 Malignant tumors of
the brain 0 - 0 - 0 - 1 254 1 362 0 - 2 162
aBeyond 95% confidence interval.
bBeyond 99% confidence interval.
Table 6. Groups for subdivision of laboratory examinations.
Group Specification
A-I VCM/PVC production
A-II PVC processing
B-I VCM/PVC production and PVC processing,
work capacity loss < 20%
B-II VCM/PVC production and PVC processing,
work capacity loss
- 20%
C-I Germans and Austrians
C-II Foreigners (Excl. Austrians)
D-I Plants with high morbidity
D-II Plants with low morbidity
Table 7. Bromsulfalein retention.a
VCM/PVC PVC
Production Processing Total
Retention normal 26 21 47
Retention abnormal 44 10 54
Total 70 31 101
aChi square, = 8.09 (p < 1%).
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Table 8. Bromsulfalein retention.a
Germans
and
Austrians Foreigners Total
Retention normal 17 30 47
Retention abnormal 33 21 55
Total 50 51 101
aChi square1 = 6.25 (p < 2.5%).
Table 9. Bromsulfalein retention.a
Work capa- Work capa-
city loss city loss
< 20% > 20% Total
Retention normal 41 6 47
Retention abnormal 32 22 54
Total 73 28 101
aChi square1 = 9.81 (p < 1%).
97(Table 4) reveals a rather inconsistent pattern:
malignancies ofthe lymphatic tissues (ICD 200-209)
are significantly elevatedinthesixtiesonly, whereas
SMRs for tumors ofthe liver increase till the end of
the study period. This might be referred to differ-
ent latency periods for both kinds of malignancies,
but other causes might likewise have contributed to
these results. However, it has to be reported that
the number of angiosarcomas confirmed histologi-
cally in the Federal Republic of Germany in pa-
tients previously exposed to VCM has actually
come to 17 in contrast to mere 4 at the endpoint of
the mortality study (12/31/1974).
The distribution of SMRs by age (Table 5)
demonstrates an obvious susceptibility of males
aged 35-44 formalignancies ingeneral as well as for
malignancies of the liver.
The data base for the German morbidity study
consists of all of the reports of suspected cases of
occupational disease due to VCM or PVC produc-
tion or PVC processing. The reference population
for these reports has to be defined as the total
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FIGURE 2. Vinyl chloride morbidity study: oral glucose toler-
ance test, 120 min after loading (normal 120 mg/dl).
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FIGURE 1. Vinyl chloride morbidity study: total bilirubin (nor-
mal 1.0).
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FIGURE 3. Vinyl chloride morbidity study: reticulocytes (nor-
mal 15%).
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MG/DLworking population in 1974 in the above mentioned
branches, i.e., 6,500 workers in VCM or PVC
production and 42,800 workers in PVC processing
(as given by the German Association of Plastic
Producing Industries). Till the end of 1974, 269
reports of suspected cases of occupational disease
had been received. As there has been no consistent
set ofexaminations performed on each ofthe cases,
numbers of observations for various variables ana-
lyzed vary according to examination method per-
formed. Insofar as the results of this study are of
much lower validity than those of the mortality
study, one should regard them as hints for further
investigations.
Four attempts to subclassify observation on the
269 cases have been undertaken (Table 6). Only
those results showing significant differences when
applying t-tests orchi-square tests are so classified.
Amazingly none ofthe more sensitive lab examina-
tions ofliver functions showed a marked difference
in all ofthe subclassifications besides bromsulfalein
retention. In this instance there is a significant
difference when subdividing by VCM/PVC produc-
tion versus processing (Table 7), as well as by
nationality (Table 8) and most pronounced when
subdividing by extent of work capacity loss (Table
9). This latter result, however, must be expected
when an effect of exposure on liver function is
anticipated. An impairment of the excretory liver
function is suggested by elevated total bilirubin
values in the subgroup with work capacity loss
greater than 20% (Fig. 1). There seems to be an
impaired glucose tolerance in this group, although
observed in a small subsample only (Fig. 2), as well
as a lower number of reticulocytes (Fig. 3). The
thromocyte count in both groups was the same.
These results, however, lead to no sensible inter-
pretation, as all results attempts failed to standard-
ize the methods applied for thrombocyte counts by
various laboratories.
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